November 5, 2018

In This Issue
CMS Issues Final Medicare Physician Payment Rule
Signatures being Collected for Citizen Initiated Proposal on Physician Assisted Death
New Web-based Decision Support Tool Helps With Chronic Pain Treatment
Health Insurance Marketplace 2019 Open Enrollment Now Through December 15, 2018
AMA Urges FTC to Act on Insulin Prices
MaineGeneral to Offer X-waiver Course
Ten Takeaways from the Surgeon General's Opioid Report
"Great American Smokeout" November 15th; "Tar Wars" Anti-smoking Education
Webinar: The Changing Landscape of Retirement - Tuesday, November 13 5pm
MMA Presentation on Healthcare Issues Considered by 128th Legislature Now Available
MMA Legislative Committee's Organizational Meeting Scheduled for December 6
Upcoming Specialty Society Meetings
Next Steps in Addressing Maine's Opioid Crisis: 11/7 Presentation Scheduled
Introduction to Lean in Healthcare Full-Day Workshop on Friday, November 9
Division of Disease Surveillance Annual Infectious Disease Conference - November 14
MICIS 3-hour Opioid CME Presentation - November 26 in Portland
Enrollment Underway for Maine’s Physician Executive Leadership Institute - The Advanced Course - Deadline for Enrollment at Discounted Price: November 30th
Identifying Substance Use Early Saves Lives! - SBIRT with Motivational Interviewing Training - 1-day Sessions Offered on Dec 8, Feb 2, Mar 2, Apr 6
Physician – Leeds
Psychiatric Mental Health NP - Leeds
Psychiatric Nurse Practitioner - Nasson Health Care
Primary Care Physician
PCHC wants to add more Family Physicians at Multiple Locations!
Outpatient Internal Medicine Physician – Bangor, Maine
OB/GYN Physician Opportunity
Franklin Health Behavioral Services is seeking a BC/BE Psychiatrist/Medical Director
Internal Medicine MD or DO (BE/BC)
Podiatrist (Non-Surgical)
Internal Medicine Outpatient Physician
Seeking Medical Director for Family Medical Practice in Waterville, ME
Internal Medicine Physician
Opportunities at the VA for Volunteer Physicians

Search Back Issues


Follow Us:
AMA Urges FTC to Act on Insulin Prices

[from AMA Advocacy Update]

The AMA expressed strong concern to the Federal Trade Commission (FTC) in an Oct. 26 letter about the sharp rise in insulin prices among manufacturers. The AMA urged the agency to monitor insulin pricing and assess whether anti-competitive actions were driving higher insulin prices.

The AMA asked that the FTC recommend enforcement action against manufacturers that were engaged in anti-competitive practices to the U.S. Department of Justice. In the letter, the AMA cited lawsuits filed in 2017 against insulin manufacturers on behalf of patients that noted there were "rapid and lockstep price increases of more than 150 percent."  

In addition,Modern Healthcare (11/1, Luthi, Subscription Publication) reports that Reps. Tom Reed (R-NY) and Diane DeGette (D-CO) are asking Congress “to limit patent extensions which have allowed insulin manufacturers to stop new generics from entering the market” in order to address rising insulin costs. According to their analysis, “Experts predict that follow-on insulins could cost 20 to 40 percent less than their brand name equivalents, creating savings for patients.” The article says other proposed changes include a proposal for “PBMs and health plans to disclose how many rebates they receive and pass along,” as well as “banning the ‘pay-for-delay’ practice in which the expired patent-holding brand drug maker pays a generic manufacturer not to produce the off-patent drug.”


< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©